alexa A Phase IIb Clinical Study Of Tissue Gene-C (TG-C) In Patients With Osteoarthritis | 15279
ISSN: 2161-0533

Orthopedic & Muscular System: Current Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference and Exhibition on Orthopedics & Rheumatology

Bumsup Lee
Accepted Abstracts: Orthop Muscul Syst
DOI: 10.4172/2161-0533.S1.014
Abstract
T G-C is a gene and cell therapy for osteoarthritis that employs ex-vivo gene delivery via a retrovirally transduced chondrocytes that overexpress transforming growth factor - β1 (TGF - β1). TG-C contains non-transformed (hChonJ) and transduced (hChonJb#7) chondrocytes by the ratio of 3:1. The randomized single blind, placebo-controlled phase IIb trials were conducted to determine both safety and efficacy in patients with knee osteoarthritis. Participants (n=54) with a confirmed diagnosis of knee osteoarthritis by X-ray and MRI were randomized into the treatment group (TG-C, n=27) and the control group (saline, n=27). The primary parameter was evaluated by International Knee Document Committee (IKDC) which measures pain, sports activities, and daily function. The secondary parameters were evaluated by Western-Ontario and MacMaster University (WOMAC) score, Knee Injury and Osteoarthritis Outcome Score (KOOS), 100 mm Visual Analogue Scale (VAS) and MRI (dGEMRIC and T2). These parameters were evaluated at 12, 24 and 48 weeks post treatment. Additionally, changes in biomarkers were assessed in serum and urine samples. Safety measures, including physical exams, complete blood count, and serum chemistry, were included up to 6 months post treatment. Blood samples were screened to detect the replication competent retrovirus (RCR), retrovirally transduced cells, and TGF-β1 DNA and protein starting from 2 weeks up to 6 months post treatment. TG-C treatment showed improvement at 24 weeks post treatment as assessed by the primary and the secondary evaluation parameters when compared to placebo control in summary, this Phase IIb study indicated that TG-C treatment improved pain, sports activities, and quality of daily life in patients with knee osteoarthritis when compared to the placebo control
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7